Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 8/20 | 0.42 |
| ▸ | AVPR1B | P47901 | 8/20 | 0.42 |
| ▸ | AVPR2 | P30518 | 7/20 | 0.42 |
| ▸ | MTTP | P55157 | 6/20 | 0.41 |
| ▸ | NPY2R | P49146 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7743963 | 0.99 | AVPR2 (0.42) | AVPR1AAVPR1BAVPR2MTTPNPY2R | |
| SCHEMBL7369121 | 0.96 | AVPR2 (0.41) | AVPR1AAVPR1BAVPR2MTTPNPY2R | |
| SCHEMBL7374548 | 0.91 | AVPR2 (0.51) | AVPR1AAVPR1BAVPR2MTTP | |
| Hydrochloric Acid SCHEMBL7372858 | 0.87 | AVPR1A (0.46) | AVPR1AAVPR1BAVPR2MTTPF10 | |
| Hydrochloric Acid SCHEMBL7368868 | 0.86 | AVPR2 (0.48) | AVPR1AAVPR1BAVPR2MTTP | |
| Hydrochloric Acid SCHEMBL7743953 | 0.86 | AVPR2 (0.43) | AVPR1AAVPR1BAVPR2MTTP | |
| SCHEMBL7743965 | 0.86 | AVPR2 (0.52) | AVPR1AAVPR1BAVPR2MTTP | |
| SCHEMBL7749369 | 0.86 | AVPR2 (0.49) | AVPR1AAVPR1BAVPR2MTTP | |
| SCHEMBL7372148 | 0.85 | MTTP (0.44) | AVPR1AAVPR1BAVPR2MTTP | |
| SCHEMBL7373974 | 0.85 | AVPR2 (0.47) | AVPR1AAVPR1BAVPR2MTTP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995029152-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-11-02 | — | — | WO | disclosed |